(Q44071055)

29 November 2017

title

Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment (English)

1 reference

29 November 2017

main subject

hepatocellular carcinoma

1 reference

3

Sylvie Dubois

1 reference

29 November 2017

Antonio Sa Cunha

1

1 reference

29 November 2017

Eric Bonte

2

1 reference

29 November 2017

Yves Chrétien

4

1 reference

29 November 2017

Tatyana Eraiser

5

1 reference

29 November 2017

Claude Degott

6

1 reference

29 November 2017

Christian Bréchot

7

1 reference

29 November 2017

Phuong-Lan Tran

8

1 reference

29 November 2017

publication date

1 August 2002

1 reference

29 November 2017

published in

Journal of Hepatology

1 reference

29 November 2017

volume

37

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

222-230

1 reference

Trends in primary liver cancer

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Hepatocellular carcinoma: Recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Early hepatocellular carcinoma as an entity with a high rate of surgical cure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Local ablation therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Immune system in suicide-gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Potentiation of the bystander effect by immunization combined with suicide gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900111-3

7 January 2021

10.1016/S0168-8278(02)00111-3

Identifiers

DOI

1 reference

29 November 2017

1 reference